2019
DOI: 10.1080/09273948.2019.1643027
|View full text |Cite
|
Sign up to set email alerts
|

Sub-Tenon Sustained Controllable Delivery of Dexamethasone for Treating Severe Acute Experimental Uveitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(4 citation statements)
references
References 35 publications
0
4
0
Order By: Relevance
“…It has been shown that severe ocular inflammation could be observed in experimental uveitis models. 25 In the current study, we started the treatment 24 hours after the model induction when severe intraocular inflammation occurred. The clinical inflammatory scores of the anterior chamber and vitreous humor in the control group were gradually increased over time, whereas those in the SI group and SMS group were decreased.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…It has been shown that severe ocular inflammation could be observed in experimental uveitis models. 25 In the current study, we started the treatment 24 hours after the model induction when severe intraocular inflammation occurred. The clinical inflammatory scores of the anterior chamber and vitreous humor in the control group were gradually increased over time, whereas those in the SI group and SMS group were decreased.…”
Section: Discussionmentioning
confidence: 99%
“…In the SMS group, after anesthesia, rabbits were administered SMS in the left eyes (Figure 1), which was prepared according to our previous study. 25 Briefly, a catheter with a micro-needle (BD Intima Ⅱ Closed IV Catheter System, Becton, Dickinson Co., USA) was inserted into sub-Tenon space, the micro-needle was then removed and a catheter was placed between the Tenon's capsule and sclera, approximately 5 mm past the limbus in the superior temporal quadrant of the left eye. After that, 0.3 mL of 20 mg/mL CP (0.2 g, Jiangsu Shengdi Pharmaceutical Co., Ltd., Jiangsu, China) was released into the sub-Tenon as the initial dosage.…”
Section: In Vivo Studymentioning
confidence: 99%
See 2 more Smart Citations